Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Darya-Varia Laboratoria TbkISX:DVLA 74 Days Inventory is 138.61 as of Mar. 2026, which is 6% below its 10-year median of 147.80. GuruFocus rates ISX:DVLA with a GF Score™ of 74/100 and a GF Value™ of Rp1,846.12 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 923 Drug Manufacturers companies, PT Darya-Varia Laboratoria Tbk ranks better than 55.15% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
PT Darya-Varia Laboratoria Tbk's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.66.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PT Darya-Varia Laboratoria Tbk's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.75.
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
PT Darya-Varia Laboratoria Tbk's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PT Darya-Varia Laboratoria Tbk's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
PT Darya-Varia Laboratoria Tbk Days Inventory Related Terms
PT Darya-Varia Laboratoria Tbk Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Darya-Varia Laboratoria Tbk Days Inventory Chart
ISX:DVLA vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PT Darya-Varia Laboratoria Tbk's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Darya-Varia Laboratoria Tbk Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Darya-Varia Laboratoria Tbk's Days Inventory distribution charts can be found below:
* The bar in red indicates where PT Darya-Varia Laboratoria Tbk's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) has a Days Inventory of 138.61 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. This is near median its historical median of 147.80. Over the past decade, PT Darya-Varia Laboratoria Tbk's Days Inventory has ranged from 110.74 to 191.47. According to the industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #414 out of 923 companies in the Drug Manufacturers industry, placing it in the top 44.9%.
Is PT Darya-Varia Laboratoria Tbk's Days Inventory too high?
PT Darya-Varia Laboratoria Tbk's current Days Inventory of 138.61 is near median its 10-year median of 147.80. Over the past 10 years, this metric has ranged from a low of 110.74 to a high of 191.47. The Drug Manufacturers industry median Days Inventory is 164.38. PT Darya-Varia Laboratoria Tbk's value of 138.61 is 15.7% below this industry median. Based on the distribution chart, PT Darya-Varia Laboratoria Tbk ranks #414 out of 923 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, PT Darya-Varia Laboratoria Tbk has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Darya-Varia Laboratoria Tbk's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #414 out of 923 companies for Days Inventory. This puts PT Darya-Varia Laboratoria Tbk in the upper half of its industry. The industry median Days Inventory is 164.38. PT Darya-Varia Laboratoria Tbk's value of 138.61 is 15.7% below this benchmark. Historically, PT Darya-Varia Laboratoria Tbk's own Days Inventory has ranged from 110.74 to 191.47 over the past decade. While the company's 10-year median is 147.80 vs. the industry median of 164.38, PT Darya-Varia Laboratoria Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Darya-Varia Laboratoria Tbk's current Days Inventory of 138.61 is 15.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Darya-Varia Laboratoria Tbk's current Days Inventory is 138.61, which is near median its own 10-year median of 147.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Darya-Varia Laboratoria Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk (ISX:DVLA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp1,846.12, compared to a current price of Rp1,560.00 — trading 15.5% below its estimated fair value. The current Days Inventory is 138.61, which is near median its 10-year median of 147.80 and 15.7% below the Drug Manufacturers industry median of 164.38. PT Darya-Varia Laboratoria Tbk's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For PT Darya-Varia Laboratoria Tbk (ISX:DVLA), the current Days Inventory is 138.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk stock appears to be undervalued.
The current stock price of Rp1,560.00 is trading 15.5% below its estimated GF Value™ of Rp1,846.12.
GuruFocus considers PT Darya-Varia Laboratoria Tbk to be Modestly Undervalued.
Key valuation signals for ISX:DVLA:
Days Inventory: 138.61 (near median its 10-year median of 147.80)
GF Value™: Rp1,846.12 vs. price of Rp1,560.00 (15.5% below fair value)
Industry Position: 15.7% below the Drug Manufacturers median (#414 of 923)
No single metric tells the full story. See the ISX:DVLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Darya-Varia Laboratoria Tbk Business Description
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, and equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics, wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory testing services, periodic inspection services, and many more activities. Its business segments include: prescription drugs; consumer health products, which derives key revenue; export and toll manufacturing services; and services.
74GF Score
Get the complete analysis for ISX:DVLA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:DVLA has been successfully added to your 
